Organigram Global Inc. reports developments tied to its Canadian cannabis cultivation, processing, branded adult-use products and cannabinoid beverage business. The company operates through subsidiaries including Organigram Inc., a licensed cultivator and processor, and participates in U.S. and Canadian cannabinoid beverages through Collective Project Limited.
Recurring news themes for OGI include operating and financial results, cannabis product launches, brand extensions, international partnership activity, and regulatory matters under Health Canada’s Cannabis Act and Cannabis Regulations. Company updates also cover brands such as Edison, Big Bag O’ Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK; the FAST nanoemulsion technology platform; and production, edibles, extraction, packaging and fulfillment facilities in Canada.
Organigram Holdings Inc. (NASDAQ: OGI) has announced the launch of its new value brand, HOLY MOUNTAIN, focused on affordable whole flower and concentrates. The initial offerings include dried flower strains like R*NTZ and MAC-1, alongside a pressed hash product. This expansion aims to enhance accessibility for consumers across Canada. Organigram is a leading cannabis producer, with plans to continue innovating and responding to consumer demands.
Organigram Holdings Inc. (NASDAQ: OGI) will report its earnings results for the fiscal year and fourth quarter ended August 31, 2022 on November 28, 2022, after market close. The company will conduct a conference call on November 29, 2022, at 8:00 am ET, to discuss these results. Interested participants can register for the call through a provided link. Organigram is a leading cannabis producer in Canada, focused on high-quality cannabis products for patients and recreational consumers.
Organigram is set to supply InterCure with up to 20,000 kg of dried cannabis flower over several years, following a successful 3,000 kg supply agreement fulfilled since June 2020. This new multi-year agreement includes an initial commitment of 10,000 kg with an option for an additional 10,000 kg within three years. Approximately 2,800 kg has already been delivered. The collaboration aims to support both companies’ international expansion strategies, contingent upon compliance with local regulations.
Organigram achieved a record net revenue of $38.1 million in Q3 Fiscal 2022, marking an 88% increase from the previous year. Gross revenue also saw a 90% rise to $55.2 million. The company maintained a 7.8% market share among Canadian licensed producers and remained the top player in dried flower products. New SKUs were introduced, including SHRED-X vapes and CBN Bedtime Blueberry Lemon gummies. However, net loss decreased to $2.8 million, and cash reserves fell by 31% year-over-year.
Organigram Holdings Inc. (NASDAQ: OGI) announced it will report its earnings results for Q3 2022, ending May 31, 2022, on July 14, 2022, before the market opens. A conference call is scheduled for the same day at 8:00 am Eastern Time to discuss the results. Interested participants can register through provided links and access the live call or a replay later. Organigram, a licensed producer of cannabis and cannabis-derived products in Canada, focuses on high-quality products for patients and adult recreational consumers.
Organigram Holdings (OGI) announced its Q2 results ending February 28, 2022, showcasing a remarkable 128% increase in gross revenue to $43.9 million and a net revenue surge of 117% to $31.8 million, marking the highest in company history. The company achieved positive Adjusted EBITDA of $1.6 million two quarters earlier than forecasted. Additionally, it gained a 8.2% market share in Canada, maintaining its top position in the dried flower category. The successful integration of the Laurentian acquisition further boosts its portfolio and market presence.
Organigram Holdings Inc. (NASDAQ: OGI), a top cannabis producer, will report its second quarter 2022 earnings results on April 12, 2022, prior to market opening. The Company will hold a conference call on the same day at 8:00 am ET to discuss the results. Interested parties can register for the call through a provided link and also access a webcast of the discussion. A replay will be available within 24 hours after the call concludes. Organigram focuses on producing quality cannabis products and expanding its international presence.
Organigram Holdings Inc. (NASDAQ: OGI) reports strong market share growth, maintaining the #3 position among Canadian licensed producers and the #1 position in dried flower. The integration of Laurentian Holdings is on track, with expected expansion of its distribution network across nine provinces. New product launches include premium dried flower strains and SHRED’ems line extensions, indicating a commitment to innovation and consumer demand. Overall, these developments support Organigram's market strategy and potential for continued growth.
Organigram Holdings has launched its social impact strategy, ‘Organigram Operating for Good’, aimed at fostering healthy communities. The company has committed to the Pledge 1% Movement, donating 1% of employee time to local volunteer initiatives across Canada. CEO Beena Goldenberg emphasized the importance of community support, stating that as their corporate footprint expands, so should their ability to contribute positively. This initiative aligns with Organigram's ongoing social giving efforts, highlighting a commitment to corporate social responsibility.
Organigram Holdings Inc. (NASDAQ: OGI) announced a C$6.3 million investment from BAT, increasing its equity ownership from 18.8% to 19.5% as of December 31, 2021. This investment follows a previous strategic stake of C$221 million in March 2021, aimed at enhancing product development collaborations. The additional funds will strengthen Organigram's balance sheet, adding to its existing cash position of C$168 million. The company is focused on innovative cannabis products, with the collaboration celebrating its first anniversary on March 10, 2022.